Self-healing hydrogels: How flexible polymer chains repair cracks and create stable structures
© generated with AI, Gemini and Tobias Hase

From defect analysis in semiconductors using positrons to cancer therapy using neutrons: Research at the MLZ receives 7.6 million euros in funding from the BMFTR.
© Astrid Eckert, FRM II / TUM

Neutron research shows that the microstructure of solvents influences nanomaterials more strongly than previously assumed.
© Bernhard Ludewig, FRM II / TUM

Proteins from green biomass open up new avenues for sustainable plant-based foods
© Bernhard Ludewig, FRM II / TUM and Karin Jähne / Adobe Stock

On four paws in action: rescue dogs train to search for missing persons at FRM II
© Andrea Voit, FRM II / TUM

TÜV NORD supports PhD student Liliana Quintero Zambrano's research into molten salt for climate-friendly reactors
© Laura Richter, TUM/FRM II

Why corals bleach - Neutrons from FRM II help investigate the processes involved in coral death
© generated with AI, Gemini, edited by Reiner Müller, FRM II / TUM

From pacemakers to dentures – a research team involving the MLZ has investigated how medical implants can be made more stable and durable.
© Bernhard Ludewig, FRM II / TUM

Simple rules, powerful insights: neutrons decode eye-lens proteins and age-related disease.
© Wenzel Schürmann/TUM

New magnetic materials open up promising prospects for next-generation electronics.
© Yixi Su / JCNS

TUM commits to nuclear research: Christian Reiter becomes Professor of Applied Nuclear Technology.
© Christoph Leonhardt, InAlpinus Design

In the series ‘We need neutrons’, researchers report on how neutron research can help to overcome the major challenges of our time.
© KFN, Ellen Fogh/TUM

Confirmed in last instance: FRM II legally in operation
© Adobe Stock / Drubig-Photo

Learn more about us.
© Andreas Heddergott FRM II / TUM

MLZ - Neutrons for Research and Innovation

Forschungs-Neutronenquelle
Heinz Maier-Leibnitz (FRM II)

The Forschungs-Neutronenquelle Heinz Maier-Leibnitz (FRM II) is a Corporate Research Center of the Technical University of Munich (TUM) located on the premises of the modern research campus in Garching.

Here, neutrons and positrons enable a wide range of applications in research, industry and medicine: from developing new technologies, such as batteries for electric cars, to precise anti-cancer drugs.

RSS

Events

29.04.2026

FRM II goes TUM Sustainability Day (Public event)

04.05.2026

Understanding Novel Emulsions - properties and structure over many length scales studied by scattering (Seminar: Neutrons in Research and Industry)

11.05.2026

Advanced Neutron Techniques for Additive Manufacturing Research (Seminar: Neutrons in Research and Industry)

18.05.2026

Prelude to neutron methods for heritage science (Seminar)

19.05.2026

International Conference on Neutrons in Heritage Science (Conference)

15.06.2026

Neutrons and Food 8 (Conference)

06.07.2026

MLZ Conference 2026: Neutrons for Future Health (Conference)

03.09.2026

TUM-Expertenforum 2026 (Industry event)

05.09.2026

02.12.2026

MLZ User Meeting 2026 (Conference)

News

Dr. Ivana Pivarníková from the Advanced Materials group, who completed her PhD at the Heinz Maier-Leibnitz Zentrum (MLZ), has received the Edward Steers Memorial Award for Best Glow Discharge Paper. The award…

The 14th SasView Contributor Camp brought together students, postdocs, established researchers, and software engineers in Garching for a week-long hackathon designed to advance SasView, the open-source…

Neutron Source

The FRM II is one of the most powerful and modern neutron sources worldwide.

Research

The Heinz Maier-Leibnitz Zentrum (MLZ) - cutting-edge research with neutrons and positrons at the FRM II.

Join us!

You would like to work at FRM II?
Here you can find our current job offers.

Industry

Material analysis, component testing and irradiation for the automotive, aerospace and semiconductor industries as well as for mechanical engineering, chemicals, medical technology ...

Medicine

In addition to radioisotopes for the diagnosis and treatment of tumor diseases, the FRM II also has a facility for the teletherapy of malignant tumors.